Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 Pneumonia

NCT05290441 is registered in ClinicalTrials.gov with Bursa Yuksek Ihtisas Training and Research Hospital as lead sponsor.

NCT NCT05290441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05290441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 Pneumonia
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 15, 2021
Completion date
December 1, 2022
Enrollment
65 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, egfr amplification, pneumonia, viral